Please click here to obtain permission to reproduce this image.

Click on image to view larger version.


Figure 5


Figure 5 Platelet Inhibition With Clopidogrel as Stratified by BMI

Increased body mass index (BMI) (≥25 kg/m2) remains independently associated with lower platelet inhibition with clopidogrel regardless of diabetic status or fibrinogen level. The adjusted platelet inhibition (mean ± SD) in subjects with high and normal BMI is shown. p < 0.001.